Doctors from applicant hospitals are not allowed to participate in the deliberation committee for the super expensive drug, Soliris
Restriction is now placed for medical doctors the related hospital which applied for the insurance benefit of the paroxysmal nocturnal hemoglobinuria(PNH) treatment, Soliris Inj(eculizumab), not to be involved with voting for the deliberation committee.
Though, if necessary to provide new medica...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
